Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

Gelijkaardige items

• Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
  door: Brusasco, V, et al.
  Gepubliceerd in: (2003)
• Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids
  door: Hodder, Richard, et al.
  Gepubliceerd in: (2007)
• The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study)
  door: Beeh, Kai-Michael, et al.
  Gepubliceerd in: (2016)
• Tiotropium Bromide/Olodaterol (Stiolto Respimat): Once-Daily Combination Therapy for the Maintenance of COPD
  door: Mosley, Juan F., et al.
  Gepubliceerd in: (2016)
• Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat(®) in Asthma Using Standardized Sample-Contamination Avoidance
  door: Beeh, Kai-Michael, et al.
  Gepubliceerd in: (2016)